This event (June 6th) has been organized by Fundació Althaia, Unió Consorci Fundació and Societat Catalana de Naonociència i Nanotecnologia. https://www.ucf.cat/wp-content/uploads/2018/05/jornada_nanotecnologia_aplicada_a_la_medicina.pdf?mc_cid=0a67fecc7e&mc_eid=b5b475a388
Next January 25th, the festival that will revolutionize the entrepreneurial ecosystem arrives in Barcelona: http://iqstechfactory.com/
Nanomol Technologies has begun its participation in the project Nano-Nafres (COMRDI15-1-0023) that belongs to the RIS3CAT community “Technologies applied to health”. The objective of this project is to perform preclinical and clinical studies on the application of nanoformulated epithelial growth factor in venous ulcers. This project has been cofounded 50% by the European Regional Development Funds from the European Union within the framework of the operative...
The project has started on January 1st, 2017, and will run for 4 years with 10 partners and a budget of 5,800,000 €. The research of Smart-4-Fabry project concerns development of drug delivery systems based on liposomes for treatment of Fabry disease. Advanced formulation and characterization techniques will be used for achieving excellent quality control over the assembly of the different molecular components of a new liposomal nano-formulation which contains the α-Galactosidase A (GLA)...
Nanomol Technologies has been present in Catalan media (Televisió de Catalunya TV3 and La Vanguardia) with the announcement that together with The Center of Genetic Engineering and Biotecnology (CIGB-Biocubafarma) and Heber Biotec it has started to clinically validate a new drug that aims at improving the healing of diabetic foot ulcers and preventing amputation. More information at: http://www.ccma.cat/tv3/alacarta/valor-afegit/fer-negocis-despres-de-fidel/video/5636552/ http://www.ccma.cat/tv3/alacarta/telenoticies-migdia/telenoticies-migdia-07122016/video/5636311/ http://icmab.es/images/attachments/2016/Reportatge_NANOMOL_TECH_La_Vanguardia_18_12_2016_CAT.pdf